NEOG INVESTOR ALERT: Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration of its business with 3M's Food Safety Division [1][3]. Company Overview - Neogen Corporation engages in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Class Action Details - The class action lawsuit is titled "Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation" and allows investors who purchased Neogen common stock between January 5, 2023, and June 3, 2025, to seek appointment as lead plaintiff by September 16, 2025 [1][7]. Allegations Against Neogen - The lawsuit alleges that Neogen's executives made false statements about the progress of the integration with 3M, leading investors to believe it was going well, while downplaying inefficiencies that arose during the process [3][4]. - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a stock price drop of over 5% [4]. - On April 9, 2025, Neogen announced a loss of $11 million for the third quarter of 2025, a significant increase from a $2 million loss the previous year, and reported a 3.4% revenue decline to $221 million, resulting in a 28% drop in stock price [5]. - On June 4, 2025, Neogen projected a drop in EBITDA margin to the high teens from 22%, attributing this to elevated inventory write-offs, which caused the stock price to fall more than 17% [6]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Neogen common stock during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8][9].